Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.82
Delayed Data
As of 3:59pm ET
 +0.27 / +2.83%
Today’s Change
6.96
Today|||52-Week Range
19.63
-43.34%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close9.55
Today’s open9.57
Day’s range9.51 - 9.90
Volume1,340,326
Average volume (3 months)1,350,759
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-263.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book28.46

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.93+2.13%
CHRSCoherus BioSciences ...+0.04+0.14%
XLRNAcceleron Pharma Inc+0.56+1.89%
RLYPRelypsa Inc+0.01+0.03%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers

Search for Jobs